Daily Routine and Access to Care: Initial Patient Reported Experiences at a German Lung Cancer Center during the COVID-19 Pandemic

Documenti analoghi

• Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies
  di: Kauffmann-Guerrero, Diego, et al.
  Pubblicazione: (2019)
• Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies
  di: Bickert, Christiane, et al.
  Pubblicazione: (2021)
• Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis
  di: Julia Walter, et al.
  Pubblicazione: (2025-07-01)
• Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
  di: Kauffmann-Guerrero, Diego, et al.
  Pubblicazione: (2021)
• Late-onset severe pneumonitis under osimertinib
  di: Syunyaeva, Zulfiya, et al.
  Pubblicazione: (2019)